Category Archives: Southeast

IsoRay, Inc., a Richland-based developer of therapies for prostate and other cancers, recently announced the first Cesium-131 colon cancer treatment. The company has also provided Cesium-131 seeds to Canada for research initiatives into treatments for other cancers. In 2009 the … Continue reading →

IsoRay, Inc., a Richland-based developer of therapies for prostate and other cancers, has announced two new distribution agreements. Inter V Medical of Montreal, Quebec, Canada will have exclusive rights to sell Cesium-131 Brachytherapy seeds in Canada. GE Subsidary, Oncura will … Continue reading →

IsoRay, Inc., a Richland-based developer of therapies for prostate and other cancers, has announced that the world’s first Cesium-131 lung implants have been performed at Cornell Medical Center. Related external links (will open a new window): IsoRay announces world’s first … Continue reading →

IsoRay, Inc., a Richland-based developer of therapies for prostate and other cancers, has announced the first head and neck cancer treated with Cesium-131. Dwight Babcock, IsoRay’s CEO, stated “This is an important development in our strategy to significantly broaden our … Continue reading →